• Our Vision

    Sujan Biologics’ intention is to develop therapeutic biologic drugs against cancer, and other diseases induced by inflammation, such as arthritis, psoriasis, etc. We recognize and value the financial hurdles the patients face everyday.

    Our vision is to provide affordable healthcare to less privileged patients.

Mission

The company’s mission is to improve the quality of health worldwide (especially cancer, autoimmune and cardiovascular diseases) by providing access to advanced therapies that down regulate chronic inflammation at the molecular level and modulates the level of cellular immunity. The Company is empowered with a full range of potential therapies; set forth in the scientific founders books, publications.

Scientific Founders

Our scientific founders have a special interest in inflammation as a root cause of disease. Underlying chronic inflammation is a causative factor in various diseases, including cancer, cardiovascular diseases, obesity, diabetes, pulmonary diseases, neurological diseases, arthritis, psoriasis, Crohn’s disease, and liver diseases.

Products

The global biologics market is expected to reach $248 billion by 2020, a compound annual growth rate (CAGR) of 9.9%. Driving this growth is the need for a more extensive drug pipeline, attractive targets against challenging diseases. a push to pursue biosimilars, and enabling manufacturing technologies that reduce the cost to produce profitable products.

For business development and partnership opportunities.

Contact Us